A recent study conducted by researchers at Queen Mary University of London unveiled a new mechanism through which cells ...
Following the discovery of a bacteria in the 1960s, it took three decades to isolate rapamycin—an immunosuppressant used in cancer treatments and organ transplantations. Although rapamycin eventually ...
New data shows Telomir-1 fully reverses STAT1 gene silencing by DNA methylation - a key immune regulator suppressed in cancer - delivering stronger epigenetic effects than Paclitaxel or Rapamycin in ...